# Small Molecule High-Throughput Screen Using AstraZeneca Facilities

**Funder:** Medical Research Council (MRC)
**Budget:** Up to £270,000 FEC (£250,000 cost to MRC)
**Deadline:** 28 January 2027 (16:00 UK time)
**Duration:** 12-18 months (typically 15 months)
**Consortium:** Required - host research organisation with AstraZeneca providing screening facilities and technical input
**Application:** Single stage
**Frequency:** Annual
**Eligible countries:** GB
**Official call:** https://www.ukri.org/opportunity/small-molecule-high-throughput-screen-using-astrazeneca-facilities/
**Last updated:** 13 Sept 2026

## Eligibility & scope

Supports academic researchers (excluding international research organisations and commercial-led applications) to discover small molecule drug starting points using AstraZeneca's compound library and HTS facilities. MRC funds up to four projects per year; researchers are encouraged to embed at AstraZeneca's Cambridge site for up to three months.

---

Source: [The Great Grantsby](https://grantsby.eu/grants/medical-research-council-mrc-small-molecule-high-throughput-screen-using-astraz-2027-01) — EU grant monitoring for academic researchers. Always verify details on the funder's website before applying.

**See which EU calls match your profile.** [Preview your matches in 30 seconds, no signup](https://grantsby.eu/demo?ref=llm_grant_md).